Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : NVID International -- Ignore unavailable to you. Want to Upgrade?

To: KGoodson who wrote (2694)	11/17/1998 12:52:00 PM
From: Debra&Jeff	Read Replies (1) \| Respond to of 3244

More news Kerry... biz.yahoo.com Tuesday November 17, 11:59 am Eastern Time Company Press Release NVID International Inc. to Benefit From Agreement CLEARWATER, Fla.--(BUSINESS WIRE)--Nov. 17, 1998--NVID International Inc. (OTC BB:NVID) announced Tuesday that Wallace & Tiernan Ltd. and EHPC Ionization Ltd. (EHPCI) have executed a ''Non-Exclusive License to Manufacture a Non-Patented Product'' that grants Wallace & Tiernan Ltd. licensing rights to manufacture and market the RMS technology, a non-halogen system for water disinfection. In a previous agreement between NVID, Aqua Bio Technologies, EHPC Ltd., and EHPCI (''Distribution Agreement''), Aqua Bio was awarded the sole distribution rights for North America. In anticipation of EHPCI's agreement with Wallace & Tiernan Ltd., the Distribution Agreement provides that Aqua Bio will receive one-fifth of the license fee received by EHPCI from Wallace & Tiernan Ltd. Additionally, Aqua Bio will receive a royalty of 12.5% of the quoted list price for each unit sold in North America by Wallace & Tiernan Ltd. for a period of five years. NVID will be purchasing RMS units directly from Wallace & Tiernan Ltd. Wallace & Tiernan Ltd. is the leading supplier of chemical feed equipment used in the treatment and disinfection of potable water/wastewater, and has offices in the U.S., Germany, England, Canada, Mexico, Brazil and Australia. The RMS is the first non-halogen disinfection system developed that can effectively treat large volumes of water. It is designed to be a cost effective alternative to the use of halogens (chlorine), for water disinfection in either single pass or re-circulating systems. The RMS non-halogen disinfection system technology delivers ionic silver utilizing proprietary assayed electrodes as the method for water disinfection. The ions are metered into the process water by dosing pumps based upon flow rates which ensures a precise dosage of ions in parts-per-billion or parts-per-million of a long-term disinfecting residual of ion concentrate. Generation of the ion concentrate is produced off-line without utilizing the process water, which enables the unit to produce ions much more effectively and efficiently as compared to conventional systems. The technology is designed to enhance the disinfection properties of halogens at lower levels, and or be a cost effective alternative to halogens in many market niches where traditional disinfection methodologies are currently being employed. In addition, the RMS technology will help solve the bio-film issue that plagues most piping distribution systems, in which halogens alone have not been able to effectively eliminate or control. Installation sites that have proven successful in England include Heathrow Airport (Queens Building) where all of the incoming main water is treated to remove bio-film from the piping distribution system for bacteria and Legionella control. Kew Gardens, an internationally known botanical center employs 10 ionization units in the watering systems to eliminate bio-film and control pythium, algae, fungi and Legionella. The RMS technology treats all of the incoming main water for bio-film removal and Legionella control at Charing Cross Hospital, Royal Free Hospital and The Royal National Orthopaedic Hospital Trust in London. Also, the contract for the British Broadcasting Company Television Centre building in London for control of bio-film and Legionella has been successfully tendered by EHPCI. Additional potential markets for this technology include drinking water, horticulture applications in green houses, golf course and hydroponics operations for pythium (a spore which commonly attacks and destroys seedlings) control, swimming pools and spas, microbiological and algae control for cooling towers, sewage effluent, irrigation water and bio-film removal in piping distribution systems and RO membranes. This press release contains forward-looking statements with respect to the future activities of the company. These forward-looking statements by their very nature involve risks and uncertainties. The industry in which the company operates is dynamic and intensely competitive and there are many factors that could cause the forward-looking statements contained herein not to occur or the timing of their occurrence to be delayed. NVID International Inc. and Aqua Bio Technologies Inc. can be reached by e-mail: aquabiotech@home.com Contact: Corporate Office David Larson, 727/669-5005, fax 727/669-4701 or Sales Office Michael Redden, 941/312-9100, fax 941/312-9300 Jeff